In this study, a reduced 50 species
373 elementary chemical mechanism
is developed for the high-temperature combustion of H2/CO/C1–C4 compounds. The reduced skeletal mechanism,
based on the detailed skeletal USC 2.0 mechanism (111 species, 784
reactions), is used to study the ignition and combustion characteristics
of the H2/H2–CO and C1–C4 hydrocarbons. It is found that the reduced skeletal mechanism
can reproduce the results from the detailed USC 2.0 mechanism with
a maximum error of less than 12% in the ignition delay times under
a range of operating conditions with P = 1–20
atm, T = 900–2000 K, and ϕ = 0.3–2.0.
The applicability of the reduced skeletal mechanism is then demonstrated
numerically in an industrial gas swirl burner for a 100% C3H8 + air non-premixed turbulent swirl-stabilized flame.
The profiles of radial temperature and mole fraction of CO at various
axial distances are validated with existing experimental data and
are found to be in good agreement. It is therefore established that
the reduced skeletal mechanism can be utilized for rapid implementation
in a commercial computational fluid dynamics (CFD) package for combustion
analysis. It is found that the central-processing-unit (CPU) time
cost of the skeletal mechanism is about one-third of that of the detailed
USC Mech 2.0 mechanism for the ignition delay and laminar flame speed
simulations and is about half of that of the detailed USC Mech 2.0
for non-premixed CFD simulations using a laminar flamelet approach.
The present results demonstrate that the reduced skeletal mechanism
can provide better scope for studying the combustion characteristics
of C1–C4 hydrocarbons at different pressure
conditions and compositions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.